Skip to main content
Log in

Downward trend in antibiotic expenditures in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. including carbapenem, polymyxin, glycopeptide, chloramphenicol, metronidazole, lipopetide and lipoglyucopeptide subclasses

Reference

  • Suda KJ, et al. Antibiotic Expenditures by Medication, Class, and Health Care Setting in the United States, 2010-2015. Clinical Infectious Diseases : 25 Aug 2017. Available from: URL: http://doi.org/10.1093/cid/cix773

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Downward trend in antibiotic expenditures in the US. PharmacoEcon Outcomes News 790, 11 (2017). https://doi.org/10.1007/s40274-017-4456-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4456-z

Navigation